MUSC sets new record as state's biomedical research leader with more than $276.5 million in funding
MUSC Health patient becomes first in state to be treated with new flexible stent
Hollings Cancer Center researchers hope to find less toxic, more effective treatment.
The hormone FGF23 is linked to structural deficits in the brain
Researchers say advisories may be warranted.
Featured Researchers: MUSC College of Medicine
Nathan Dolloff, Ph.D.
Assistant Professor of Cell and Molecular Pharmacology, Developmental Cancer Therapeutics
MUSC Science Café
invites you to learn about science and technology in a fun, comfortable environment.
Date: October 16, 2018
Time: 5:30 p.m.
480 King Street
Charleston, SC 29403
Come learn about state-of-the-art tissue engineering and how it is used to improve patient outcomes!
Join us at the Science Café to hear Dr. Michael Yost talk on tissue engineering and 3D bioprinting and how it holds the promise of customized living implants for patients who have lost tissue due to trauma, disease or genetic disability.
In the News
MUSC breaks record in funding for biomedical research (10/18/18)
$11 million NIH grant creates new center for musculoskeletal research (10/18/18)
Brain surgery: predicting patient outcomes (10/16/18)
New MUSC study demonstrates value of seeking a second opinion for breast cancer patients (10/15/18)
'Like a hug from everyone who loves you' — how MDMA could help patients with trauma (10/15/18)
High levels of toxic PCBs found in Charleston Harbor fish by MUSC researchers (10/11/18)
Molecular imaging research could find less toxic, more effective breast cancer treatments (10/8/18)
Sexual Assault Has Long-Term Mental, Physical Impact (10/3/18)
Contact Us: Office of the Vice President for Research | 179 Ashley Ave, MSC 001 | Charleston, SC 29425 | 843-792-4333 | email@example.com